Vaxart, Inc (VXRT) Dividend History

Company News

• Vaxart Announces Preliminary Results of Annual Meeting of Stockholders

  Vaxart, a clinical-stage biotechnology company, held its Annual Meeting of Stockholders. Preliminary results show that two proposals were approved and two were rejected by stockholders. The company is evaluating its options regarding the rejected proposals.

  GlobeNewswire Inc.
• Vaxart Stock Is Moving Higher After The Bell: What's Going On?

  Vaxart Inc (NASDAQ:VXRT) shares are trading higher in Monday’s after-hours session after the company provided business and cash runway updates. What Happened: Vaxart, a clinical-stage biotechnology company developing a range of oral recombinant vaccines, announced Monday that proceeds from a recent offering combined with reimbursements under its Project NextGen award are expected to extend the company’s cash runway into 2026. “The past week was especially important for Vaxart, because the combination of receiving one of the largest Project NextGen awards from BARDA and closing our $40 million financing from leading ...Full story available on Benzinga.com

  Benzinga
• Beat the Market Like Zacks: Walmart, Novo Nordisk, Procter & Gamble in Focus

  Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.

  Zacks Investment Research

  Featured Companies: ACMR AZO CL OCUL PG SFM SLDB WMT
• These 2 Stocks Carry a Lot of Risk, but Their Upside Is Huge

  Novavax and Vaxart have each dropped more than 80% over the past year.

  The Motley Fool

  Featured Companies: NVAX
• Best Penny Stocks To Buy? 4 To Watch Before 2023

  Penny stocks to watch before next year. The post Best Penny Stocks To Buy? 4 To Watch Before 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

  PennyStocks

  Featured Companies: AKBA PLX